## Metabolic Classification: Hyperglycemic Hyperosmolar State with Mild Ketosis ### Clinical Context Recognition **Key Point:** This patient presents with: - Marked hyperglycemia (320 mg/dL) with high osmolality (310 mOsm/kg) - Mild metabolic acidosis (pH 7.32, HCO₃⁻ 18) — not severe - Mildly elevated ketones (1.5 mmol/L) — not the dominant feature - Preserved consciousness (no severe DKA) - Type 2 diabetes (residual β-cell function) This constellation defines **hyperglycemic hyperosmolar state (HHS) with concurrent mild ketosis**, not pure DKA. ### Why This Is NOT Euglycemic Ketoacidosis **Warning:** Euglycemic ketoacidosis (EKA) occurs at blood glucose <250 mg/dL with normal or near-normal glucose. This patient's glucose is 320 mg/dL, ruling out EKA. EKA is also typically associated with SGLT2 inhibitor use or type 1 diabetes, not type 2. ### Why This Is NOT Starvation Ketoacidosis The patient has type 2 diabetes with poor glycemic control, not a history of prolonged fasting. Starvation ketoacidosis develops over days of fasting and presents with lower glucose levels and mild acidosis, but the clinical context (diabetes, hyperglycemia) does not fit. ### Why This Is NOT Alcoholic Ketoacidosis There is no mention of alcohol use. Alcoholic ketoacidosis develops in chronic alcoholics after acute cessation of drinking and typically presents with lower glucose (often <200 mg/dL) and more severe acidosis. ### Pathophysiology of HHS with Mild Ketosis ```mermaid flowchart TD A[Type 2 Diabetes + Poor Control]:::outcome --> B[Relative Insulin Deficiency] B --> C{Degree of Insulin Deficiency}:::decision C -->|Severe| D[Uncontrolled Lipolysis]:::action C -->|Moderate| E[Partial Lipolysis + Hyperglycemia]:::action D --> F[Massive FFA Release]:::outcome E --> F F --> G[Hepatic Ketogenesis]:::action G --> H[Ketone Accumulation] B --> I[Impaired Glucose Uptake]:::action I --> J[Severe Hyperglycemia]:::outcome J --> K[Osmotic Diuresis]:::action K --> L[Volume Depletion + Hyperosmolality]:::urgent H --> M[Mild Ketosis] L --> N[HHS with Mild Ketosis]:::outcome ``` ### Source of Ketone Bodies **High-Yield:** In HHS with mild ketosis, ketones are derived from **adipose tissue lipolysis** (FFA release) driven by the relative insulin deficiency. However, the degree of lipolysis is less severe than in DKA because: 1. Type 2 diabetes retains some β-cell function → some residual insulin effect 2. The hyperglycemia itself provides some osmotic brake on lipolysis 3. The primary pathology is impaired glucose clearance, not complete insulin loss **Mnemonic: HHS vs. DKA — "Glucose Osmolality Rule"** - **HHS:** Glucose >600 mg/dL, osmolality >320 mOsm/kg, ketones mild or absent - **DKA:** Glucose 250–600 mg/dL, osmolality <320 mOsm/kg, ketones marked (>5 mmol/L) ### Role of Glucagon While the glucagon-to-insulin ratio is elevated in this patient (contributing to ketogenesis), the **primary source** of ketone bodies is the FFA substrate released by lipolysis. Glucagon stimulates ketogenesis, but without FFA substrate, ketogenesis cannot occur. The FFA comes from adipose tissue lipolysis. [cite:Harrison 21e Ch 397; Endocrinology and Metabolism Clinics of North America 2015] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.